ATE437223T1 - Attenuiertes bovines respiratorisches syncytialvirus - Google Patents

Attenuiertes bovines respiratorisches syncytialvirus

Info

Publication number
ATE437223T1
ATE437223T1 AT01938170T AT01938170T ATE437223T1 AT E437223 T1 ATE437223 T1 AT E437223T1 AT 01938170 T AT01938170 T AT 01938170T AT 01938170 T AT01938170 T AT 01938170T AT E437223 T1 ATE437223 T1 AT E437223T1
Authority
AT
Austria
Prior art keywords
respiratory syncytial
bovine respiratory
attenuate
syncytial virus
viruses
Prior art date
Application number
AT01938170T
Other languages
English (en)
Inventor
Ulrike Schmidt
Ursula Buchholz
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE437223T1 publication Critical patent/ATE437223T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
AT01938170T 2000-06-23 2001-05-02 Attenuiertes bovines respiratorisches syncytialvirus ATE437223T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202183 2000-06-23
PCT/EP2001/005085 WO2002002752A1 (en) 2000-06-23 2001-05-02 Attenuated bovine respiratory syncytial virus

Publications (1)

Publication Number Publication Date
ATE437223T1 true ATE437223T1 (de) 2009-08-15

Family

ID=8171676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938170T ATE437223T1 (de) 2000-06-23 2001-05-02 Attenuiertes bovines respiratorisches syncytialvirus

Country Status (9)

Country Link
US (2) US6921535B2 (de)
EP (1) EP1297110B1 (de)
AT (1) ATE437223T1 (de)
AU (1) AU2001263896A1 (de)
CA (1) CA2412075C (de)
DE (1) DE60139319D1 (de)
DK (1) DK1297110T3 (de)
ES (1) ES2330411T3 (de)
WO (1) WO2002002752A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001263896A1 (en) * 2000-06-23 2002-01-14 Akzo Nobel N.V. Attenuated bovine respiratory syncytial virus
US7355716B2 (en) * 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
NZ548107A (en) * 2003-12-24 2009-09-25 Nederlanden Staat A respiratory syncytial virus with a genomic deficiency complemented in trans
ES2526170T3 (es) * 2004-12-23 2015-01-07 Medimmune, Llc Línea celular MDCK no tumorigénica para propagar virus
AU2007347716B2 (en) * 2006-09-15 2013-06-20 Medimmune, Llc MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
KR20110074563A (ko) * 2008-09-24 2011-06-30 메디뮨 엘엘씨 바이러스의 정제 방법
CN102216450B (zh) * 2008-09-24 2014-05-14 米迪缪尼有限公司 培养细胞、增殖和纯化病毒的方法
US9061001B2 (en) * 2008-10-16 2015-06-23 University Of Saskatchewan Combination adjuvant formulation
AR084358A1 (es) * 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
CN105734007B (zh) * 2016-03-10 2019-06-07 金宇保灵生物药品有限公司 一种筛选对牛病毒性腹泻/黏膜病毒敏感的mdbk细胞系的方法
US20220315953A1 (en) * 2019-06-07 2022-10-06 Intervet Inc. Mdbk irf3/irf7 knock out mutant cell and its use for vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0702085T4 (da) * 1994-07-18 2010-04-06 Conzelmann Karl Klaus Prof Dr Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
US6699476B1 (en) * 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
EP0912724B1 (de) 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen
EP0974660A1 (de) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
AU2001263896A1 (en) * 2000-06-23 2002-01-14 Akzo Nobel N.V. Attenuated bovine respiratory syncytial virus

Also Published As

Publication number Publication date
CA2412075A1 (en) 2002-01-10
EP1297110A1 (de) 2003-04-02
DK1297110T3 (da) 2009-11-16
US20050186224A1 (en) 2005-08-25
ES2330411T3 (es) 2009-12-10
US6921535B2 (en) 2005-07-26
WO2002002752A1 (en) 2002-01-10
EP1297110B1 (de) 2009-07-22
US20040037850A1 (en) 2004-02-26
CA2412075C (en) 2011-09-20
DE60139319D1 (en) 2009-09-03
AU2001263896A1 (en) 2002-01-14
US7335366B2 (en) 2008-02-26

Similar Documents

Publication Publication Date Title
AU4185001A (en) Protein scaffolds for antibody mimics and other binding proteins
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE60328885D1 (de) Verfahren zur Beurteilung eines Krankheitzustandes mittels Nachweis von partikel- und nicht partikelgebundenen Nukleinsäuren in Blutplasma und -serum
DK1297110T3 (da) Attenueret bovin respiratorisk syncytialvirus
ATE384785T1 (de) Herstellung von viren, virusisolaten, und impfstoffen
DE60236965D1 (de) Coronavirus-ähnliche partikel enthaltende funktionell deletierte genome
DE69816286D1 (de) Verfahren zur Erkennung von Nukleinsäuremethylierungen durch AFLP
ATE439592T1 (de) Proteingerüste für antikörper-nachahmer und andere bindende proteine
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
DE69936948D1 (de) Virusenthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten
ATE492813T1 (de) Verfahren zur isolierung von analyten aus einer probe
DK0486515T3 (da) Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
HU230068B1 (hu) Nemhagyományos transzmisszibilis ágens biológiai mintabeli jelenlétének kimutatásán alapuló eljárás szubakut transzmisszibilis spongiform encephalopathia diagnózisára
SE9602496D0 (sv) Method and means for producing a fibrinogen binding protein and its use in biotechnology
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
ATE487792T1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
DE69928688D1 (de) Verfahren zur identifizierung von punkt mutationen in einem genom
DE60117998D1 (de) Mutierte furin polypeptide, welche verbesserte eigenschaften aufweisen
ATE288589T1 (de) Verfahren zur analyse von proteinen
DE50200452D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
Holmes et al. Coronavirus receptor specificity
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
Gambini et al. New mouse model for inducible hACE2 expression enables to dissect SARS-CoV-2 pathology beyond the respiratory system
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1297110

Country of ref document: EP

REN Ceased due to non-payment of the annual fee